OTC:GRVE
GROOVE BOTANICALS INC.
A capital-intensive cannabis distributor with substantial cash reserves but currently reporting zero revenue and significant operating losses.
Key Metrics
Investment Thesis
Bull Case
Investors might consider GRVE if they believe the company can successfully pivot its business model to generate revenue within the next 1-2 years using its existing capital reserves. The substantial paid-in capital provides a runway for strategic acquisitions or partnerships that could unlock value in the growing cannabis sector. A successful rebranding or product launch could turn the current deficit into profitability quickly.
Bear Case
The stock is highly speculative given the complete absence of revenue and a retained earnings deficit exceeding $35M. Investors face the danger of significant dilution as the company burns cash without generating income to cover its dividend obligations. The financial structure shows total liabilities matching total assets, leaving no real equity cushion for operational failures or market downturns.
About GROOVE BOTANICALS INC.
GROOVE BOTANICALS INC. (GRVE) is a cannabis-focused entity operating within the competitive recreational and medical marijuana markets. The company utilizes a specialized distribution network to deliver high-quality botanical products to licensed retailers and dispensaries across North America. Despite recent financial reporting indicating zero recorded revenue, the firm maintains significant paid-in capital while navigating a landscape of strict regulatory compliance.
Analysis
Management Discussion
Management has secured $34.0M in paid-in capital which currently sits as cash and equivalents of $2.0M alongside a massive dividend liability of $356,940, indicating potential restructuring needs. The company reported a net loss of $130,834 driven entirely by operating expenses with zero revenue, suggesting the business is in a pre-revenue or restructuring phase. Cash flow from operations was negative at -$107,422 while financing activities provided a one-time inflow of $107,776, likely related to equity issuance.
Industry Overview
The cannabis industry is a rapidly evolving sector characterized by strict federal and state-level regulatory hurdles that vary significantly by region. Companies in this space often require substantial upfront capital for licensing, cultivation infrastructure, and distribution networks before achieving profitability. Market consolidation is common as smaller operators struggle with high cost structures and regulatory compliance costs.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Expenses | $266.6K | $130.8K |
| Operating Income | $-266.6K | $-130.8K |
| G&A | $73.7K | $73.1K |
| Other OpEx | $192.8K | $57.7K |
| Non-Operating Income | $0 | $0 |
| Pre-Tax Income | $-266.6K | $-130.8K |
| Income Tax | $-112.8K | $0 |
| Continuing Ops | $-153.8K | $-130.8K |
| Discontinued Ops | $0 | $0 |
| Net Income | $-153.8K | $-130.8K |
| Minority Interest | $0 | $0 |
| Net to Common | $-153.8K | $-130.8K |
| Metric | 2024 | 2025 |
|---|---|---|
| Current Assets | $2.1K | $4.5K |
| Cash & Equivalents | $1.7K | $2.0K |
| Other Current Assets | $454 | $2.5K |
| Long-Term Assets | $0 | $0 |
| Total Assets | $2.1K | $4.5K |
| Current Liabilities | $762.7K | $1.1M |
| Other Current Liab | $544.2K | $757.4K |
| Long-Term Liabilities | $0 | $0 |
| Total Liabilities | $762.7K | $1.1M |
| Shareholders' Equity | $-760.6K | $-1.1M |
| Paid-In Capital | $34.0M | $34.0M |
| Retained Earnings | $-34.8M | $-35.2M |
| Total L&E | $2.1K | $4.5K |
| Metric | 2024 | 2025 |
|---|---|---|
| Net Income (CFO) | $-153.8K | $-130.8K |
| Non-Cash Adjustments | $-27.7K | $-4.0K |
| Working Capital Changes | $94.6K | $27.5K |
| Cash from Operations | $-86.8K | $-107.4K |
| Cash from Investing | $0 | $0 |
| Cash from Financing | $84.0K | $107.8K |
| FX Effect | $0 | $0 |
| Net Change in Cash | $-2.9K | $354 |
| Beginning Cash | $4.6K | $1.7K |
| Ending Cash | $1.7K | $2.0K |
Frequently Asked Questions
How does GROOVE BOTANICALS INC. make money?
The company's primary segments include wholesale distribution of recreational marijuana products, potential medical cannabis channels for qualifying patients, and ancillary services such as cultivation support or logistics, though current financials show no active revenue generation in these areas.
What are the main risks for GRVE?
Significant risk of continued operating losses with no immediate revenue stream, substantial non-current liabilities relative to minimal assets, potential dilution from ongoing equity raises to fund operations, and regulatory uncertainty that could impact future product approvals or sales.
What is GRVE's competitive advantage?
Access to a proprietary licensing framework that may provide barriers to entry in specific jurisdictions, a strategic network of industry partnerships aimed at future market penetration, and the ability to raise capital through equity financing despite current cash burn.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.